Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone) Clinical Trials Resources presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, visits or professional assistance with a real medical. We aren't doctors. Always consult your mD about Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone) conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone) Clinical research trials and Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone) health trials occur in a lot of of places throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new does drugs. The role of the studies / projects is to resolve certain human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector corporations to detect remedies for all varieties of circumstances, such as Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone). Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone) Clinical Trials and other clinical trials allow volunteers to obtain health treatment choices before they are available to the general public. Most times the human subjects recieve professional assistance for free of charge, and every now and again they are paid for their time. Sometimes there is a cost for a Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone) clinical trial. Human subjects frequently get the finest healthcare available for their Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone) condition. Risks are a reality, however, and may include extra or frequent physician visits, medical dangers (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with strict guidelines to protect clinical trials patients.

Home > "T" Clinical Trials Conditions > Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone)

Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone)



Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone)

For Condition: Alcoholism,Smoking
Status: Recruiting
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: The purpose of this study is to determine the effectiveness of naltrexone (Revia) in reducing drinking and smoking in patients with both nicotine and alcohol dependence. Individuals will be randomly assigned to a 12-week trial of a fixed daily dose of either naltrexone (Revia) and nicotine replacement patch or placebos. All individuals will receive weekly coping skills and smoking-cessation behavioral therapy. Followup interviews will be conducted 3 and 6 months after treatment to determine smoking and drinking status and persistence of any dependence symptoms.
Details:
Eligibility:
Study Type:  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study
Minimum Age/Maximum Age: 18 Years/65 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Meets criteria for alcohol dependence and nicotine dependence. - Expresses a desire to cut down or stop drinking and smoking. Exclusion Criteria: - Currently meets criteria for dependence on substances other than alcohol and nicotine. - Any history of opiate dependence or evidence of current opiate use. - Significant medical disorders that will increase potential risk or interfere with study participation. - Liver function tests more than 3 times normal or elevated bilirubin. - Females who are pregnant, nursing, or not using a reliable method of birth control. - Meets criteria for a major psychiatric disorder and is in need of or currently undergoing drug therapy. - Inability to understand and/or comply with the provisions of the protocol and consent form. - Treatment with an investigational drug during the previous month. - Chronic treatment with any narcotic-containing medications during the previous month. - Sensitivity to drug as evidenced by adverse drug experiences especially with narcotic- containing analgesics or opioid antagonists. - Current treatment with disulfiram (Antabuse) or nicotine replacement therapy. - More than 6 weeks of abstinence.
Total Enrollment: 166

Location and Contact Information:

Department of Psychiatry, University of Miami School of Medicine *Recruiting*
Miami,  Florida,  33136
United States
Recruiting Dr.  Mason 305-243-4644


Additional Information:
Study ID Numbers:  NIAAAMAS11210; 
Study Start Date: 
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000437

Other Smoking Studies:
1. Preliminary Human Trial of NPI-028

2. Ondansetron Treatment for Alcoholism

3. Timing of Smoking Intervention in Alcohol Treatment (nicotine patch)

4. Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone)

5. Use of Naltrexone in a Clinical Setting

Related Studies:

Other Smoking Clinical Trials
Other Florida Clinical Trials
Other Miami Clinical Trials

Tobacco Dependence in Alcoholism Treatment (nicotine patch/naltrexone)
Modify your Search

  Other Smoking Clinical Trials
  Other Florida Clinical Trials
  Other Miami Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103